Skip to main content
SpringerLink
Log in

Therapy for Interstitial Cystitis/Bladder Pain Syndrome and Other Forms of Pelvic Pain During Pregnancy

  • Chapter
  • First Online:
Urological and Gynaecological Chronic Pelvic Pain

  • 974 Accesses

Abstract

Pelvic pain is a common condition in women and has a prevalence ranging from 16 to 25 % [1]. There are several potential etiologies of chronic pelvic pain in women and they include disorders of the gynecologic, urologic, gastrointestinal, musculoskeletal, and nervous systems [2]. Pelvic pain unique to pregnancy is even more common, occurring in 48–56 % of all pregnancies [3]. More specifically, a recent cross-sectional study in the United States demonstrated that two thirds of a cohort of pregnant patients reported back and pelvic pain [4]. The pain often starts in the first trimester of pregnancy and worsens as the pregnancy progresses [5]. Many healthcare providers are apprehensive about treating pain in pregnant patients due to risks associated with the various therapeutic interventions during pregnancy; it is estimated that over 50 % of the women receive little or no intervention from their healthcare providers [4]. However, for many pregnant patients, pain can interfere with daily activities, disturb sleep, and can lead to disability/sick leave. Subsequently, for physicians, familiarity with common pain problems as well as the maternal and fetal risks associated with the therapeutic interventions will prevent and ameliorate these outcomes and achieve a more comfortable pregnancy. The intent of the present chapter is to focus on management options in women with preexisting chronic gynecologic and urologic pain syndromes who subsequently become pregnant. We will discuss the treatments options of chronic pain syndromes in pregnancy, as well as highlight issues that need to be taken into consideration when dealing with pain therapy in pregnancy. Important to acknowledge is that every attempt was made to make the discussion that follows to be evidence-based however, there is paucity of research in this domain due to the subjective nature of the condition, lack of universally recognized classification system, and limited research in pregnant population [6].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Grace VM, Zondervan KT. Chronic pelvic pain in New Zealand: prevalence, pain severity, diagnosis and use of the health services. Aust N Z J Public Health. 2004;28:369–75.

    Article  PubMed  Google Scholar 

  2. Nelson P, et al. Chronic female pelvic pain - part 2: differential diagnosis and management. Pain Pract. 2012;12(2):111–41.

    Article  PubMed  Google Scholar 

  3. Mens JM, et al. Understanding peripartum pelvic pain. Implications of a patient survey. Spine. 1996;21:1363–70.

    Article  CAS  PubMed  Google Scholar 

  4. Skaggs CD, Prather H, Gross G, George JW, Thompson PA, Nelson DM. Back and pelvic pain in an underserved United States pregnant population. J Manipulative Physiol Ther. 2007;30(2):130–4.

    Article  PubMed  Google Scholar 

  5. MacLennan AH, MacLennan SC. Symptom-giving pelvic girdle relaxation of pregnancy, postnatal pelvic joint syndrome and developmental dysplasia of the hip. Acta Obstet Gynecol Scand. 1997;76:760–4.

    Article  CAS  PubMed  Google Scholar 

  6. Liddle SS. Interventions for preventing and treating low-back and pelvic pain during pregnancy. Cochrane Database Syst Rev. 2015;9, CD001139.

    Google Scholar 

  7. Teng J, Wang ZY, Bjorling DE. Estrogen-induced proliferation of urothelial cells is modulated by nerve growth factor. Am J Physiol Renal Physiol. 2002;282(6):F1075–83.

    Article  CAS  PubMed  Google Scholar 

  8. Teng J, Wang ZY, Bjorling DE. Progesterone induces the proliferation of urothelial cells in an epidermal growth factor dependent manner. J Urol. 2003;170(5):2014–8.

    Article  CAS  PubMed  Google Scholar 

  9. Hanno PM, et al. Painful bladder syndrome/interstitial cystitis. Chapter 23.

    Google Scholar 

  10. Erickson DR, Propert KJ. Pregnancy and interstitial cystitis/painful bladder syndrome. Urol Clin N Am. 2007;34:61–9.

    Article  Google Scholar 

  11. Erikson DR, Propert KJ. Pregnancy and interstitial cystitis/painful bladder syndrome. Urol Clin N Am. 2007;34:61–9.

    Article  Google Scholar 

  12. Whitmore KE. Self-care regimens for patients with interstitial cystitis. Urol Clin North Am. 1994;21(1):121–30.

    CAS  PubMed  Google Scholar 

  13. Law H, Fiadjoe P. Urogynaecological problems in pregnancy. J Obstet Gynaecol. 2012;32:109–12.

    Article  CAS  PubMed  Google Scholar 

  14. Simon LJ, Landis JR, Erickson DR, Nyberg LM. The interstitial cystitis data base study: concepts and preliminary baseline descriptive statistics. Urology. 1997;49(5A Suppl):64–75.

    Article  CAS  PubMed  Google Scholar 

  15. Hanno PM, et al. AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol. 2011;185(6):2162.

    Article  PubMed  Google Scholar 

  16. Milunsky A, et al. Maternal heat exposure and neural tube defects. JAMA. 1992;268(7):882–5.

    Article  CAS  PubMed  Google Scholar 

  17. Hanno PM, Erickson D, Moldwin R, Faraday MM. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment. J Urol. 2015;193(5):1545.

    Article  PubMed  Google Scholar 

  18. Wilson JJG, Fraser FC. Handbook of teratology, vol 1: general principles and etiology. New York, NY: Plenum; 1977. p. 49–62.

    Book  Google Scholar 

  19. Pregnancy and lactation labeling rule. http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/Labeling/ucm093307.htm. PLLR or final rule.

  20. Nagpal G, Rathmell J. Managing pain during pregnancy and lactation. Pract Manag Pain 35:474–491

  21. Rebordosa C, Kogevinas M, Horváth-Puho E, et al. Acetaminophen use during pregnancy: effects on risk of congenital abnormalities. Am J Obstet Gynecol. 2008;198:178e1–7.

    Article  CAS  Google Scholar 

  22. Slone D, Heinonen OP, Kaufman DW, et al. Aspiring and congenital malformations. Lancet. 1976;1:1373–5.

    Article  CAS  PubMed  Google Scholar 

  23. Alano MA, Ngougmna E, Ostrea EM, et al. Analysis of nonsteroidal antiinflammatory drugs in meconium and its relation to persistent pulmonary hypertension of the newborn. Pediatrics. 2001;107:519–23.

    Article  CAS  PubMed  Google Scholar 

  24. Broussard CS, Rasmussen SA, Reefhuis J, et al. Maternal treatment with opioid analgesics and risk for birth defects. National Birth Defects Prevention Study. Am J Obstet Gynecol. 2011;204:314.

    Article  PubMed  CAS  Google Scholar 

  25. Rementeria JL, Nunaq NN. Narcotic withdrawal in pregnancy: stillbirth incidence with a case report. Am J Obstet Gynecol. 1973;116:1153–6.

    Article  Google Scholar 

  26. Jones H, Johnson R, Jasinski D, et al. Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome. Drug Alcohol Depend. 2005;79:1–10.

    Article  CAS  PubMed  Google Scholar 

  27. Pfizer. Gabapentin prescribing information. New York, NY: Pfizer; 1996.

    Google Scholar 

  28. Petrere JA, Anderson JA. Developmental toxicity studies in mice, rats, and rabbits with the anticonvulsant gabapentin. Fundam Appl Toxicol. 1994;23:585–9.

    Article  CAS  PubMed  Google Scholar 

  29. Rosa F. Holoprosencephaly and antiepileptic exposures. Teratology. 1995;51:230.

    Article  CAS  PubMed  Google Scholar 

  30. Briggs GG, Freeman RK, Yaffe SJ. Gabapentin. Drugs in pregnancy and lactation, update. Drugs. 1997;10:2–3.

    Google Scholar 

  31. Bruni J. Women’s issues in the treatment of epilepsy. Can J Neurol Sci. 1998;25:S19–23.

    Article  CAS  PubMed  Google Scholar 

  32. Fujii H, Goel A, Bernard N, Pistelli A, Yates LM, Stephens S, Han JY, Matsui D, Etwell F, Einarson TR, Koren G, Einarson A. Pregnancy outcomes following gabapentin use: results of a prospective comparative cohort study. Neurology. 2013;80(17):1565–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Molgaard-Nielsen D, Hviid A. Newer-generation antiepileptic drugs and the risk of major birth defects. JAMA. 2011;305(19):1996–2002.

    Article  PubMed  Google Scholar 

  34. Almgren M, Kallen B, Lavebratt C. Population-based study of antiepileptic drug exposure in utero—influence on head circumference in newborns. Seizure. 2009;18(10):672–5.

    Article  PubMed  Google Scholar 

  35. Montouris G. Gabapentin exposure in human pregnancy: results from the Gabapentin Pregnancy Registry. Epilepsy Behav. 2003;4:310–7.

    Article  PubMed  Google Scholar 

  36. Forestier F, Fischer AM, Daffos F, et al. Absence of transplacental passage of pentosan polysulfate during mid trimester of pregnancy. Thromb Haemost. 1986;56(3):247–9.

    CAS  PubMed  Google Scholar 

  37. Product Information. Elmiron(R), pentostan polysulfate sodium. Miami, FL: Baker Norton Pharmaceuticals, Inc.; 2002.

    Google Scholar 

  38. Beyer BK, et al. Incidence and potentiation of external and internal fetal anomalies from chlordiazepoxide and amitriptyline alone and in combination. Teratology. 1984;30:39–45.

    Article  CAS  PubMed  Google Scholar 

  39. Guram MS, et al. Comparative teratogenicity of chlordiazepoxide, amitriptyline, and a combination of the two compounds in the fetal hamster. Neurotoxicology (Park Forest, IL). 1982;3:83–90.

    CAS  Google Scholar 

  40. Bracken MB, Holford TR. Exposure to prescribed drugs in pregnancy and association with congenital malformations. Obstet Gynecol. 1981;58:336–44.

    CAS  PubMed  Google Scholar 

  41. Barson AJ. Malformed infant. Br Med J. 1972;2:45.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Freeman R. Limb deformities: possible association with drugs. Med J Aust. 1972;1:606–7.

    CAS  PubMed  Google Scholar 

  43. Heinonen OP, et al. Birth defects and drugs in pregnancy. Littleton, MA: Littleton Publishing Sciences Group; 1977. p. 328, 335–7, 341, 438.

    Google Scholar 

  44. Nulman I, Rovet J, Stewart DE, et al. Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med. 1997;336:258–62.

    Article  CAS  PubMed  Google Scholar 

  45. Shearer WT, et al. Urinary retention in a neonate secondary to maternal ingestion of nortriptyline. J Pediatr. 1972;81:570–2.

    Article  CAS  PubMed  Google Scholar 

  46. Webster PA. Withdrawal symptoms in neonates associated with maternal antidepressant therapy. Lancet. 1973;2:318–9.

    Article  CAS  PubMed  Google Scholar 

  47. Eggermont E. Withdrawal symptoms in neonate associated with maternal imipramine therapy. Lancet. 1973;2:680.

    Article  CAS  PubMed  Google Scholar 

  48. Shrand H. Agoraphobia and imipramine withdrawal? Pediatrics. 1982;70:825.

    CAS  PubMed  Google Scholar 

  49. King CTG, Howell J. Teratogenic effect of buclizine and hydroxyzine in the rat and chlorcyclizine in the mouse. Am J Obstet Gynecol. 1966;95:109–11.

    Article  CAS  PubMed  Google Scholar 

  50. Walker BE, Patterson A. Induction of cleft palate in mice by tranquilizers and barbiturates. Teratology. 1974;10:159.

    Article  CAS  PubMed  Google Scholar 

  51. Earl FL, et al. Teratogenic research in beagle dogs and miniature swine. The laboratory animal in drug testing: 5th symposium, internal committee on laboratory animals, 5th Fischer, Stuttgart; 1973, p. 233–247.

    Google Scholar 

  52. Steffek AJ, et al. Abortive effects and comparative metabolism of chlorcyclizine in various mammalian species. Teratology. 1968;1:399–406.

    Article  CAS  PubMed  Google Scholar 

  53. Narrod SA, et al. Metabolism of meclizine in the rat. J Pharmacol Exp Ther. 1965;147:380–4.

    CAS  PubMed  Google Scholar 

  54. Hilbert J, Radwanski E, Affrime MB, Perentesis G, Symchowicz S, Zampaglione N. Excretion of loratadine in human breast milk. J Clin Pharmacol. 1988;28:234–9.

    Article  CAS  PubMed  Google Scholar 

  55. Posner HS, Darr A. Fetal edema from benzhydroylpoperizines as a possible cause of oral-facial malformations in the rat. Toxicol Appl Pharmacol. 1970;17:67–75.

    Article  CAS  PubMed  Google Scholar 

  56. Erez S, et al. Double-blind evaluation of hydroxyzine as an antiemetic in pregnancy. J Reprod Med. 1971;7:57–9.

    Google Scholar 

  57. Einarson A, Bailey B, Jung G, Spizzirri JD, Baillie M, Koren G. Prospective controlled study of hydroxyzine and cetirizine in pregnancy. Ann Allergy Asthma Immunol. 1997;78:183–6.

    Article  CAS  PubMed  Google Scholar 

  58. Diav-Citrin O, Shechtman S, Aharonovich A, Moerman L, Arnon J, Wajnberg R, Ornoy A. Pregnancy outcome after gestational exposure to loratidine or antihistamines: a prospective controlled cohort study. J Allergy Clin Immunol. 2003;111:1239–43.

    Article  CAS  PubMed  Google Scholar 

  59. Petrie RH, et al. The effect of drugs on fetal heart rate variability. Am J Obstet Gynecol. 1978;130:294.

    CAS  PubMed  Google Scholar 

  60. Serreau R, Komiha M, Blanc F, Guillot F, Jacqz-Aigrain E. Neonatal seizures associated with maternal hydroxyzine hydrochloride in late pregnancy. Reprod Toxicol. 2005;20:573–4.

    Article  CAS  PubMed  Google Scholar 

  61. Prenner BM. Neonatal withdrawal syndrome associated with hydroxyzine hydrochloride. Am J Dis Child. 1977;131:529.

    CAS  PubMed  Google Scholar 

  62. Gilbert C, Mazzotta P, Loebstein R, et al. Fetal safety of drugs used in the treatment of allergic rhinitis: a critical review. Drug Saf. 2005;28:707–19.

    Article  CAS  PubMed  Google Scholar 

  63. Perez-Marrero R, Emerson LE, Feltis JT. A controlled study of dimethyl sulfoxide in interstitial cystitis. J Urol. 1988;140(1):36.

    CAS  PubMed  Google Scholar 

  64. Peeker R, Haghsheno MA, Holmäng S, Fall M. Intravesical bacillus Calmette-Guerin and dimethyl sulfoxide for treatment of classic and nonulcer interstitial cystitis: a prospective, randomized double-blind study. J Urol. 2000;164(6):1912.

    Article  CAS  PubMed  Google Scholar 

  65. Parsons CL. Urinary tract infections. Clin Obstet Gynaecol. 1985;12:487–96.

    CAS  PubMed  Google Scholar 

  66. Ferm VH. Congenital malformations induced by dimethyl sulphoxide in the golden hamster. J Embryol Exp Morphol. 1966;16:49–54.

    CAS  PubMed  Google Scholar 

  67. Juma MB, Staples RE. Effect of maternal administration of dimethylsulfoxide on the development of rat fetuses. Proc Soc Exp Biol Med. 1967;125:567–9.

    Article  CAS  PubMed  Google Scholar 

  68. Nishimura I, Imai S. Determination of sample size and vehicle solvent in a developmental toxicology test with chick embryo. J Toxicol Sci. 2004;29:421.

    Google Scholar 

  69. Caujolle FME, et al. Limits of toxic and teratogenic tolerance of dimethyl sulfoxide. Ann N Y Acad Sci. 1967;141:11025.

    Article  Google Scholar 

  70. Theirsch JB. Investigation into the differential effect of compounds on rat litter and mother. In: Tuchmann-Duplessis H, editor. Malformations congenitales des mammiferes. Paris: Masson et Cie; 1971. p. 95–113.

    Google Scholar 

  71. Staples RE, Pecharo MM. Species specificity in DMSO teratology. Teratology. 1973;8:238.

    Google Scholar 

  72. Bariljak IR, et al. Studies on the antimutagenic and anti-teratogenic characteristics of dimexide (DMSO). Tsitol i Genet (USSR). 1978;12:50–6.

    Google Scholar 

  73. ElDeib MM, Reddy CS. Mechanism of dimethylsulfoxide protection against the teratogenicity of secalonic acid D in mice. Teratology. 1988;38:419–25.

    Article  CAS  PubMed  Google Scholar 

  74. Kawai S, Nishizawa M. New procedure for DNA transfection with polycation and dimethyl sulfoxide. Mol Cell Biol. 1987;4:1172–4.

    Article  Google Scholar 

  75. Cameron IR, et al. The infectivity of herpes simplex virus DNA in rat embryo cells is enhanced synergistically by DMSO and glucose. J Virol Methods. 1983;6:183–91.

    Article  CAS  PubMed  Google Scholar 

  76. Wilson GL. Transformation in the presence of dimethyl sulfoxide facilitates recovery of Ebstein-Barr virus. Intervirology. 1983;19:56–60.

    Article  CAS  PubMed  Google Scholar 

  77. Harvey B. Cooling of embryonic cells, isolated blastoderms, and intact embryos of the zebra fish Brachydanio rerio to −196 degrees C. Cryobiology. 1983;20:440–7.

    Article  CAS  PubMed  Google Scholar 

  78. Schneider U, Maurer RR. Factors affecting survival of frozen-thawed mouse embryos. Biol Reprod. 1983;29:121–8.

    Article  CAS  PubMed  Google Scholar 

  79. Trounson A, Mohr L. Human pregnancy following cryopreservation, thawing and transfer of an eight-cell embryo. Nature. 1983;305:707–9.

    Article  CAS  PubMed  Google Scholar 

  80. Mohr LR, Trounson AO. Cryopreservation of human embryos. Ann N Y Acad Sci. 1985;442:536–43.

    Article  CAS  PubMed  Google Scholar 

  81. Gordts S, Roziers P, Campo R, Noto V. Survival and pregnancy outcome after ultrarapid freezing of human embryos. Fertil Steril. 1990;53:469–72.

    Article  CAS  PubMed  Google Scholar 

  82. Wyns C, Curaba M, Vanabelle B, Van Langendonckt A, Donnez J. Options for fertility preservation in prepubertal boys. Hum Reprod Update. 2010;16(3):312–28.

    Article  PubMed  Google Scholar 

  83. Yildiz C, Mullen B, Jarvi K, McKerlie C, Lo KC. Effect of different cryoprotectant agents on spermatogenesis efficiency in cryopreserved and grafted neonatal mouse testicular tissue. Cryobiology. 2013;67(1):70–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Kitchin KT, Ebron MT. Further development of rodent whole embryo culture: solvent toxicity and water insoluble compound delivery system. Toxicology. 1984;30:45–57.

    Article  CAS  PubMed  Google Scholar 

  85. Tasdemir U, Buyukleblebici S, Tuncer PB, Coskun E, Ozgurtas T, Aydin FN, Buyukleblebici O, Gurcan IS. Effects of various cryoprotectants on bull sperm quality, DNA integrity and oxidative stress parameters. Cryobiology. 2013;66:38–42.

    Article  CAS  PubMed  Google Scholar 

  86. Atochem E. Dimethylsulphoxide (DMSO) 90-day repeat dose snout-only inhalation toxicity study in rats Huntingdone-life sciences, report no EFA 024/002609. PAIUCLID Data Set. Dimethyl sulfoxide. Philadelphia, PA: Atofina Chemicals Inc; 2000. http://www.epa.gov/chemrtk/pubs/summaries/dimthslf/c14721rr1.pdf.

    Google Scholar 

  87. Henry R, Patterson L, Avery N, et al. Absorption of alkalinized intravesical lidocaine in normal and inflamed bladders: a simple method for improving bladder anesthesia. J Urol. 2001;165:1900–3.

    Article  CAS  PubMed  Google Scholar 

  88. Briggs GG, Freeman RK, Yaffe SJ, editors. Lidocaine: drugs in pregnancy and lactation. 6th ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2002. p. 788–90.

    Google Scholar 

  89. Andres RL. Effects of therapeutic, diagnostic and environmental agents and exposure to social and illicit drugs. In: Creasy RK, Resnik R, editors. Maternal fetal medicine: principles and practice. 5th ed. Philadelphia, PA: WB Saunders; 2004. p. 281–314.

    Google Scholar 

  90. Cohen-Kerem R, Railton C, Oren D, Lishner M, Koren G. Pregnancy outcome following non-obstetric surgical intervention. Am J Surg. 2005;190(3):467.

    Article  PubMed  Google Scholar 

  91. Mazze RI, Källén B. Reproductive outcome after anesthesia and operation during pregnancy: a registry study of 5405 cases. Am J Obstet Gynecol. 1989;161(5):1178.

    Article  CAS  PubMed  Google Scholar 

  92. Friedman JM. Teratogen update: anesthetic agents. Teratology. 1988;37(1):69.

    Article  CAS  PubMed  Google Scholar 

  93. Davidson AJ. Anesthesia and neurotoxicity to the developing brain: the clinical relevance. Paediatr Anaesth. 2011;21(7):716–21. Epub 2011 Apr 6.

    Article  PubMed  Google Scholar 

  94. Oren D, Nulman I, Makhija M, et al. Using corticosteroids during pregnancy. Are topical, inhaled, or systemic agents associated with risk? Can Fam Phys. 2004;50:1083–5.

    CAS  Google Scholar 

  95. Govaert B, Melenhorst J, Link G, Hoogland H, van Gemert W, Baeten C. The effect of sacral nerve stimulation on uterine activity: a pilot study. Colorectal Dis. 2010;12(5):448–51.

    Article  CAS  PubMed  Google Scholar 

  96. Mamopoulos A, Stavrakis T, Mavromatidis G, Rousso D. Active sacral neuromodulator during pregnancy: a unique case report. Am J Obstet Gynecol. 2014;211(1):e4–5.

    Article  PubMed  Google Scholar 

  97. Wiseman OJ, Hombergh U, Koldewijn EL, Spinelli M, Siegel SW, Fowler CJ. Sacral neuromodulation and pregnancy. J Urol. 2002;167(1):165–8.

    Article  CAS  PubMed  Google Scholar 

  98. El-Khawand D, Montgomery OC, Wehbe SA, Whitmore KE. Sacral nerve stimulation during pregnancy: case report and review of the literature. Female Pelvic Med Reconstr Surg. 2012;18(2):127–9.

    Article  PubMed  Google Scholar 

  99. Kuo HC, Chancellor MB. Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome. BJU Int. 2009;104(5):657.

    Article  CAS  PubMed  Google Scholar 

  100. De Oliveira Monteiro E. Botulinum toxin and pregnancy. Skinmed. 2006;5(6):308.

    Article  PubMed  Google Scholar 

  101. Forrest JB, Payne CK, Erickson DR. Cyclosporine A for refractory interstitial cystitis/bladder pain syndrome: experience of 3 tertiary centers. J Urol. 2012;188(4):1186–91. Epub 2012 Aug 15.

    Article  CAS  PubMed  Google Scholar 

  102. Bäckman L, Brandt I, Appelkvist EL, Dallner G. Tissue and subcellular localizations of 3H-cyclosporine A in mice. Pharmacol Toxicol. 1988;62(2):110.

    Article  PubMed  Google Scholar 

  103. Nandakumaran M, Eldeen AS. Transfer of cyclosporine in the perfused human placenta. Dev Pharmacol Ther. 1990;15(2):101.

    CAS  PubMed  Google Scholar 

  104. Venkataramanan R, Koneru B, Wang CC, Burckart GJ, Caritis SN, Starzl TE. Cyclosporine and its metabolites in mother and baby. Transplantation. 1988;46(3):468.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  105. Østensen M, Khamashta M, Lockshin M, Parke A, Brucato A, Carp H, Doria A, Rai R, Meroni P, Cetin I, Derksen R, Branch W, Motta M, Gordon C, Ruiz-Irastorza G, Spinillo A, Friedman D, Cimaz R, Czeizel A, Piette JC, Cervera R, Levy RA, Clementi M, De Carolis S, Petri M, Shoenfeld Y, Faden D, Valesini G, Tincani A. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther. 2006;8(3):209.

    Article  PubMed  PubMed Central  Google Scholar 

  106. Cockburn I, Krupp P, Monka C. Present experience of Sandimmun in pregnancy. Transplant Proc. 1989;21(4):3730.

    CAS  PubMed  Google Scholar 

  107. Bar Oz B, Hackman R, Einarson T, Koren G. Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis. Transplantation. 2001;71(8):1051.

    Article  CAS  PubMed  Google Scholar 

  108. Leone Roberti Maggiore U, Ferrero S, Mangili G, Bergamini A, Inversetti A, Giorgione V, Viganò P, Candiani M. A systematic review on endometriosis during pregnancy: diagnosis, misdiagnosis, complications and outcomes. Hum Reprod Update. 2016;22(1):70–103. doi:10.1093/humupd/dmv045. Epub 2015 Oct 7.

    Article  PubMed  Google Scholar 

  109. Brown J, Farquhar C. Endometriosis: an overview of Cochrane reviews. Cochrane Database Syst Rev. 2014;2014:Online.

    Google Scholar 

  110. ACOG practice bulletin. Medical management of endometriosis. Number 11, Dec 1999.

    Google Scholar 

  111. ACOG practice bulletin. Alternatives to Hysterectomy in the management of Leiomyomas. Number 96, Feb 2004.

    Google Scholar 

  112. Ouyang DW, Economy KE, Norwitz ER. Obstetric complications of fibroids. Obstet Gynecol Clin North Am. 2006;33:153–69.

    Article  PubMed  Google Scholar 

  113. Dildy GA, Moise KJ, Smith LG, et al. Indomethacin for the treatment of symptomatic leiomyoma uteri during pregnancy. Am J Perinatol. 1992;9:185–9.

    Article  PubMed  Google Scholar 

  114. Rice JP, Kay HH, Mahony BS. The clinical significance of uterine leiomyomas in pregnancy. Am J Obstet Gynecol. 1989;160:1212–6.

    Article  CAS  PubMed  Google Scholar 

  115. Moridaira T, Yamamoto G, Hiraishi M, Sakuma K, Taga K. A case of continuous epidural anesthesia for pain relief in a pregnant woman with uterine myoma in the second trimester of pregnancy. Masui. 2013;62(10):1253–6.

    PubMed  Google Scholar 

  116. Mollica G, Pittini L, Minganti E, et al. Elective uterine myomectomy in pregnant women. Clin Exp Obstet Gynecol. 1996;23:168–72.

    CAS  PubMed  Google Scholar 

  117. Phillips D, Deipolyi AR, Hesketh RL, Midia M, Oklu R. Pelvic congestion syndrome: etiology of pain, diagnosis, and clinical management. J Vasc Interv Radiol. 2014;25(5):725–33.

    Article  PubMed  Google Scholar 

  118. Ignacio EA, Dua R, Sarin S, Harper AS, Yim D, Mathur V, et al. Pelvic congestion syndrome: diagnosis and treatment. Semin Intervent Radiol. 2008;25:361–8. doi:10.1055/s-0028-1102998.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Associate Professor of Obstetrics and Gynecology, University of North Dakota School of Medicine & Health Sciences, Sanford Health Maternal-Fetal Medicine, 737 Broadway N, Fargo, ND, 58122, USA

    Peter Van Eerden M.D., M.S.

  2. Albert Einstein College of Medicine/Montefiore Medical Center, New York, USA

    Saila Moni M.D.

Authors
  1. Peter Van Eerden M.D., M.S.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Saila Moni M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter Van Eerden M.D., M.S. .

Editor information

Editors and Affiliations

  1. The Arthur Smith Institute for Urology, Hofstra Northwell School of Medicine, Northwell Health, Lake Success, New York, USA

    Robert M. Moldwin

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Van Eerden, P., Moni, S. (2017). Therapy for Interstitial Cystitis/Bladder Pain Syndrome and Other Forms of Pelvic Pain During Pregnancy. In: Moldwin, R. (eds) Urological and Gynaecological Chronic Pelvic Pain. Springer, Cham. https://doi.org/10.1007/978-3-319-48464-8_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-48464-8_17

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-48462-4

  • Online ISBN: 978-3-319-48464-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation